New filler JTM102 takes on juvederm in Face-Off trial
NCT ID NCT07265778
First seen Jun 26, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This study tests a new hyaluronic acid filler called JTM102 against the well-known Juvederm VOLUMA for restoring volume in the mid-face area. About 149 adults aged 19 to 65 with mid-face volume loss will receive both fillers on different sides of their face to compare results. The goal is to see if JTM102 is as safe and effective for temporary correction.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- hyaluronic acid filler with lidocaine
- What this could lead to
- If JTM102 works as well as Juvederm, it could offer another safe option for temporarily restoring mid-face volume.
- What could go wrong
- This is a pivotal study but still early for this specific filler. Results may not show a clear advantage, and individual results vary. Risks include typical filler side effects like swelling or bruising.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MID FACE VOLUME DEFICIT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chungang University Hospital
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.